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Skin and soft tissue infections (SSTIs) represent a wide range of clinical conditions characterized by a consid-
erable variety of clinical presentations and severity. Their aetiology can also vary, with numerous possible
causative pathogens. While other authors previously published analyses on several types of SSTI and on
restricted types of patients, we conducted a large nationwide surveillance programme on behalf of the Italian
Society of Infectious and Tropical Diseases to assess the clinical and microbiological characteristics of the
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whole SSTI spectrum, from mild to severe life-threatening infections, in both inpatients and outpatients.
Twenty-five Infectious Diseases (ID) Centres throughout Italy collected prospectively data concerning both the
clinical and microbiological diagnosis of patients affected by SSTIs via an electronic case report form. All the
cases included in our database, independently from their severity, have been managed by ID specialists join-
ing the study while SSTIs from other wards/clinics have been excluded from this analysis. Here, we report
the preliminary results of our study, referring to a 12-month period (October 2016–September 2017). During
this period, the study population included 254 adult patients and a total of 291 SSTI diagnoses were posed,
with 36 patients presenting more than one SSTIs. The type of infection diagnosed, the aetiological micro-
organisms involved and some notes on their antimicrobial susceptibilities were collected and are reported
herein. The enrichment of our registry is ongoing, but these preliminary results suggest that further analysis
could soon provide useful information to better understand the national epidemiologic data and the current
clinical management of SSTIs in Italy.
Keywords: Epidemiology, microbiology, skin and soft tissue infections, registry
Introduction
Skin and soft tissue infections (SSTIs) are some of the
most commonly occurring bacterial infections, with a
wide range of possible aetiological pathogens and a
considerable variety of clinical presentations and
severity, from mild to severe life-threatening infec-
tions. The characteristic variability of such infections
makes it difficult to classify them and define their
prevalence with certainty. Moreover, many cases of
common and relatively less severe SSTIs (such as cel-
lulitis and small subcutaneous abscesses) are not rou-
tinely cultured. Therefore, in most cases the precise
microbiological causes of these infections remain
unknown.1 Given the epidemiological importance
assumed by SSTIs during the past two decades, with a
marked rise in incidence worldwide,2,3 and the paucity
of broad population-based studies on SSTIs we con-
ducted a nationwide surveillance programme to assess
the clinical and microbiological characteristics of the
whole spectrum of SSTIs (ranging from simple fol-
liculitis to severe necrotizing fasciitis). Here, we report
the preliminary results of our study and compare our
findings with those reported in the literature.
Patients and methods
Twenty-five Infectious Diseases Centres throughout
Italy (eight in the Northern, eight in Middle and
nine in Southern Italy) collected prospectively data
concerning the diagnosis and management of both
inpatients and outpatients affected by SSTI man-
aged by ID specialists, via an electronic case report
form. For each clinical case entered into the data-
base, the following information were collected:
patients’ demographic data; the setting where they
come from (community, emergency room, hospital
or long-term care facilities); type of SSTI diag-
nosed; site and size of the lesions; co-morbidities;
results of microbiological tests, including notes on
the patterns of antibiotic susceptibilities of the
microorganisms isolated; type and results of
previous treatment; type and results of current anti-
biotic treatment.
The study was approved by the local Ethical
Committee (Comitato Etico Campania Sud
approval 84/2016) for the principal investigator.
The study was approved as well by the single
Ethical Committees for each participating centre.
The study is still ongoing and only some prelim-
inary results are presented herein. The registry is
constantly expanding and the study population
increasing; in the present study, we limited our
observation to a restricted period (from October
2016 to September 2017) and we only focussed on
some of the information available in the database:
we analysed the preliminary data on the type of
infection and the aetiological agents, while a more
complete far-reaching analysis of the whole registry
will soon be undertaken.
Results
During the 12 months period, the ID specialists of
the 25 ID centres involved in the study, enrolled 254
adult patients diagnosed with SSTI: 171 males
(67.3%) and 83 females (32.7%) with a male/female
ratio of 2.06. The age range of the population was
18–98 years, with an average age of 60.04 years and a
median age of 59 years. Indeed, the highest incidence
rate of SSTI was observed in the range 50–69 years
(104 cases, 41%), often presenting a high degree of
co-morbidity, the most common being diabetes mel-
litus (30.7% of patients) and cardiovascular diseases
(30% of patients). The majority of SSTIs (55.9%)
were diagnosed in patients coming from community
rather than health care facilities.
In the 254 patients, a total of 291 diagnoses of
SSTIs were made with 36 patients presenting more
than one SSTI. The most common diagnoses were:
cellulitis (29%), erysipelas (14.1%), surgical site
infections (10.3%) and diabetic foot infection
(8.6%) as shown in Table 1. No relevant differences
of SSTI rates among the centres joining the study
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throughout the country has been found. The
majority of the lesions were located in the lower
limbs (67%), followed by higher limbs (10.2%) and
trunk (5.5%). Sixty-eight cases out of the total 291
SSTIs diagnosed in our study met the criteria for
Acute Bacterial Skin and Skin-Structure Infection
(ABSSSI) definition including the size of lesion.
Most of them were cellulitis and erysipelas (47 and
39%, respectively).
Microbiological assessment of the lesions was
performed through the culture of several specimens
depending on the particular type of infection:
superficial swabs; deep tissue biopsy and blood.
For 78 patients (30.7%), most of whom were
affected by cellulitis and erysipelas, no microbio-
logical exam was requested. For the remaining 176
patients, a total of 187 microbiological exams were
implemented (Table 2). Of the 187 exams, 45
(24.1%) did not yield bacterial growth (cellulitis,
erysipelas and surgical wound reporting the highest
failure rates for microbial assessment). Of the 142
pathogen-positive cultures, multiple micro-organ-
isms were identified in 50 cases (35.2%), surgical
wounds and diabetic foot infections accounting for
almost half of such cases (10 and 8, respectively),
while a single micro-organism was detected in the
remaining 92 cultures (64.8%). In Table 3, we pre-
sent the number of overall isolates (194 bacterial
species) yielded by the 142 positive cultures and we
further distinguish the microbiological results of
monomicrobial and polymicrobial isolates. The
most common bacterial species found as causative
agents of overall SSTIs were represented by Gram-
positive bacteria [108 (56%)] while Gram-negatives
accounted for 64 (33%) as shown in Table 3.
Staphylococcus aureus were detected in 74 cases
(38.2%), being the leading cause of such infections,
with a methicillin-resistance rate of 57% (Table 4).
The second and the third most common aetio-
logical pathogens in our database were represented
by Pseudomonas spp. and Enterococcus faecalis,
with 32 (16.5%) and 13 (6.7%) cases, respectively.
Discussion
Skin and soft tissue infections have always been
among the most common bacterial infections but
their incidence has worryingly increased worldwide
during last two decades, assuming the proportion
of a global public health threat.2–6 One of the most
recent large-scale studies conducted on the
HealthCore Integrated Research Database demon-
strated that the SSTI incidence is about 48.46
cases/1000 population year.2 Moreover, the emer-
gence of multi-drug resistant microorganisms (first
of all the notorious MRSA) and their spread, not
only among health care facilities, but also in com-
munity settings makes this phenomenon even more
alarming and the management of such infections
more challenging due to the reduced efficacy of
available antimicrobial armamentarium.7–11
Therefore, knowledge of SSTI epidemiology and
the current economic healthcare burden is crucial
to combat these infections but the range of SSTIs
is so heterogeneous and complex that, although
several classifications have been drawn up over the
years on the basis of several variables (aetiology,
localization, clinical severity… ), no classification
has received universal consensus.1,12,13 Several
authors have already published investigations on
clinical presentation and microbiological assess-
ment of SSTIs but they often limited their study
population to restricted types of patients such as
hospitalized patients, for example,14,15 or to
restricted diagnosis, such as complicated
SSTIs.14–16 Here, we report the preliminary results
of a nationwide surveillance programme including
all categories of SSTIs and patients deserving con-
sultation with an infectious diseases specialist either
in the clinic, or in the ward or in the emergency
room (from the common and uncomplicated fol-
liculitis in otherwise healthy patients to the severe
necrotizing infection in critically ill patients),
through the use of an electronic registry designed
and tailored to collect a wide range of information.
Although many SSTIs are managed by other spe-
cialists than ID specialists in surgical and clinical
wards, we did not include in our analysis the cases
from other wards than ID units and we focussed
our observation on all the cases, independently
from their severity, that came to the attention of
the ID specialists joining the study.
Table 1. SSTI diagnosis posed in the study population.
SSTI
Number of cases out of
total SSTIs (%)
Cellulitis 84 (29)
Erysipelas 41 (14.1)
Surgical site infection 30 (10.3)
Diabetic foot infection 25 (8.6)
Abscess 23 (8)
Venous ulcer 21 (7.2)
Phlegmon 19 (6.5)
Wound infection 9 (3.1)
Pressure ulcer 6 (2.1)
Impetigo 4 (1.4)
Necrotizing fasciitis 3 (1)
Hidradenitis 3 (1)
Myonecrosis 2 (0.7)
Folliculitis 1 (0.3)
Forunculosis 1 (0.3)
Clostridial myonecrosis 1 (0.3)
Bite wound infection 1 (0.3)
Other infection 17 (5.8)
Total 291
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The demographic characteristics of our study
population were similar to those of other studies
previously published, chiefly consisting of older
patients (54.3% > 60 years old) with a male/female
ratio >1, although our ratio (2.06) was consider-
ably higher than that found by Gibbons (1,38)16
and by Garau (1.36).14 Diabetes mellitus proved to
be the most frequent comorbidity among our
patients (30.7% of total patients suffering), which
means that diabetes mellitus occurs approximately
five times more frequently in SSTI patients than in
the general population, a similar percentage being
found by Garau (33,9%;14). The above data
strongly suggest that diabetics have an increased
risk of SSTIs, maybe due to impaired immunologic
response to pathogens.7,17 Moreover, although
there is no universal agreement on how far this
increased risk is directly related to diabetes, recent
large-scale investigations have demonstrated that
not only are diabetics inclined to develop SSTIs
but they also have a five times higher risk of SSTI-
associated complications compared to patients
without diabetes.18,19 It is hardly surprising that in
our registry, diabetic foot infection (DFI) is the
most frequently occurring infection in diabetics
(27.3% of SSTIs diagnosed in diabetic patients) but
it is noteworthy that also other types of infections
are often diagnosed: cellulitis (23.9%), surgical
wound infection (11.4%), abscess (10.3%) and ery-
sipelas (9.1%). Therefore, diabetics need particular
care to diagnose early on and prevent any SSTIs
(not only DFI) and their complications.
A total of 291 diagnoses of SSTIs were posed in
our registry, the most common being cellulitis, rep-
resenting 29% of overall SSTIs, followed by erysip-
elas (14.1%), surgical site infections (10.3%), DFI
(8.6%) and abscess (8%). Comparing our data with
those reported elsewhere, the percentages of cellu-
litis and abscesses appear to be lower, but it should
be noted that in many studies abscesses and cellu-
litis are considered in one category (thus the group
of cellulitis/abscess easily reaches higher percen-
tages, from 50%15 to 63%7). Furthermore, while in
our analysis 14.1% of the overall SSTIs were diag-
nosed as erysipelas, other authors considered ery-
sipelas in the same category as cellulitis/abscess
with no further distinctions. Thus, adding the per-
centages of cellulitis, abscess and erysipelas diag-
nosed in our registry we obtain a 51% that is quite
similar to previously published data. Also, the rates
of DFI (8.6%), surgical wound (10.3%) and trophic
ulcer (7.2%) are much closer to data published by
Garau et al.9 Yet it is significant that impetigo, for-
unculosis and folliculitis, representing less than 2%
Table 2. Microbiological tests performed for diagnosis.
Study population 254
Patients with no microbiological
exams performed
78
Patients with at least one
microbiological exam performed
176
Microbiological exams performed Number of cases
Superficial swab 74
Blood culture 51
Deep tissue 38
Biopsy 17
Other 7
Total 187
Table 3. Bacterial species isolated from monomicrobial and polymicrobial cultures.
Bacterial species
Number (%) of colonies
from the overall cultures
Number (%) of colonies from
the monomicrobial cultures
Number (%) of colonies from
the polymicrobial cultures
Gram positives 108 (56) 65 (70.7) 43 (42.2)
S. aureus 74 (38.2) 51 (55.4) 23 (22.6)
E. faecalis 13 (6.7) 3 (3.3) 10 (9.8)
Coag.neg. Staph. 9 (4.6) 6 (6.5) 3 (2.9)
S. agalactiae 7 (3.6) 5 (5.4) 2 (1.9)
E. faecium 4 (2.2) 0 (0) 4 (3.9)
S. pyogenes 1 (0.5) 0 (0) 1 (0.9)
Gram negatives 64 (33) 22 (24) 42 (41.2)
Pseudomonas
spp.
32 (16.5) 13 (14.1) 19 (18.6)
E. coli 13 (6.7) 3 (3.3) 10 (9.8)
Acinetobacter
spp.
6 (3.1) 2 (2.2) 4 (3.9)
Proteus spp. 5 (2.6) 2 (2.2) 3 (2.9)
Enterobacter spp. 5 (2.6) 2 (2.2) 3 (2.9)
Klebsiella spp. 3 (1.5) 0 (0) 3 (2.9)
Other species 22 (11) 5 (5.3) 17 (16.6)
Total 194 92/194 102/194
Table 4. Methicillin-resistance rate among S. aur-
eus isolated.
S. aureus 74 isolates (%)
MRSA 42 (57)
MSSA 32 (43)
SILVANO ET AL. Epidemiology and microbiology of SSTIs
12 Journal of Chemotherapy 2019 VOL. 31 NO. 1
of the SSTIs diagnosed in our study, are described
with a much higher proportion of diagnoses in
other studies (12% impetigo and 17% forunculosis
for Casey et al.20). All these differences present in
the literature in the rates of various SSTIs are due
to several biases, first of all the selection of patients
(as the frequency of some infections markedly dif-
fers between inpatients and outpatients) but also
the selection of the type of SSTI included in the
study. In our registry, we included a large cohort
of different patients and all types of SSTIs, from
mild infections not needing drugs, to severe, nec-
rotic and complicated infections with a view to rep-
resenting accurately the heterogeneous array
of SSTIs.
In our database, the microbiological exams most
often required to identify the aetiological pathogens
of the SSTI are the culture of superficial swabs,
deep tissue biopsy and blood. However, the reason
for seeking aetiological exams depends on the type
of infection. Thus, microbiological tests are not
always needed to pose the clinical diagnosis of
some less severe SSTIs or when the aetiology is
supposed to be known.21,22 Indeed, in 30.7% of the
cases in this study, the patients did not undergo a
microbiological test as it was considered unneces-
sary (most often for cellulitis, erysipelas and small
subcutaneous abscess) and antimicrobial treatment
was started without a microbial diagnosis. This
applies to a new clinical entity, recently defined by
the US Food and Drug Administration (FDA):
acute bacterial skin and skin-structure infection
(ABSSSI). ABSSSI is defined as a bacterial infec-
tion of the skin with a lesion size area of 75 cm2
(lesion size measured by the area of redness,
oedema or induration), including cellulitis/erysip-
elas, wound infections and major cutaneous
abscesses.23–25 A total of 47% of the cellulitis and
39% of the erysipelas in our registry have met the
criteria for ABSSSI definition. Such infections,
although presenting different clinical entities, share
the same aetiology (Staphylococcus aureus and/or
Streptococcus pyogenes). Hence, the appropriate
antimicrobial therapy can easily be administered
without delay.12 Yet, for most of the other SSTIs,
the identification of the causative pathogen and the
assessment of its antimicrobial susceptibility profile
can be crucial to select the most effective antibiotic
therapy, although there is no agreement on the
most reliable tool for SSTI microbiological diagno-
sis. As expected, in our registry, the superficial
swab is the most commonly adopted method for
the collection of clinical samples (74 of the 187
microbiological tests; 39.6%) while the culture of
deep tissue biopsy was performed only in 55 cases
(55/187, 29.4%). Though many authors still debate
about the rate of concordance between these two
methods,26–28 most of the guidelines indicate that
the culture of deep tissue sampling (collected by
curettage and biopsy or aspiration of infected
secretions) provides the most useful information on
the causative organisms often lying in deeper
layers, while the cultures of superficial swabs are
easily contaminated by harmless bacteria belonging
to indigenous microbial flora.26,29 Of the overall
187 microbiological exams performed in our study,
45 (24.1%) failed to detect any microorganisms;
blood culture reporting the highest negative rate
(no bacterial growth in 25 out of 52 blood cultures,
49%): indeed bacteraemia is uncommon in mild
SSTI and guidelines recommend blood cultures
only for severe SSTIs requiring hospitalisza-
tion.22,30 Upon analysing the 142 positive cultures,
we noted that multiple pathogens were isolated in
50 cases (35.2%), especially from surgical wound
and diabetic foot infections; while a single micro-
organism had been detected in the remaining 92
cultures (64.8%). In more than half of the SSTIs
(56%), Gram-positive bacteria were detected as the
aetiological pathogen. These data are very similar
to the findings of Garau et al. (57%)14 but lower
than that reported by Ray et al. (87%)7 and Tiwari
et al. (70.5%).31 S. aureus represents by far the
most common bacterial species detected also in the
other studies cited above but we found a higher
proportion of methicillin-resistance among the S.
aureus isolates (56.2% of the overall S. aureus iso-
lated were MRSA) compared to that reported by
these authors (46%7 and 27.6%14). The percentage
of Gram-negatives among the causative pathogens
was 33%, very similar to that found by Garau
et al. (35%) but differently from their results, in
which Enterobacteriaceae accounted for 25% of all
the causative agents, we found that P. aeruginosa
was the most common (16.5%), while
Enterobacteriaceae were isolated only in 10.8% of
cases. Enterococcus faecalis (6.7%), Acinetobacter
spp. (3.1%), Enterobacter spp. (2.6%), Enterococcus
faecium (2.2%), coag. neg Staphylococci (4.6%) and
S. pyogenes (0.5%) were less frequently isolated as
the role of these pathogens seems to be secondary,
as was found in other studies.
In conclusion, these preliminary results of our
nationwide surveillance programme show that the
registry, during the first 12 months period, has col-
lected a considerable amount of data, partly over-
lapping with those of previous large-scale studies
but slightly diverging from them as regards the
prevalence of some specific categories of infections,
or the different share of some aetiological agents.
Therefore, the continuous enrichment of this regis-
try until the end of the study period (2 years),
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could soon provide us useful information to repre-
sent a detailed picture of the national epidemio-
logic data and the current clinical management of
SSTIs in Italy, both for their diagnostic and thera-
peutic approach.
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